The Wyss Institute at Harvard University
25 Shattuck Street
11 articles with The Wyss Institute at Harvard University
Study Published in Nature Biomedical Engineering Demonstrates the Unique Capabilities of Torus Biosystems Donut PCR System
Torus Biosystems, Inc., a point of care molecular diagnostics company spun out of the Wyss Institute for Biologically Inspired Engineering at Harvard University, announced the publication of performance results for its Donut PCR system.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announces that it is collaborating with multiple industry partners to discover more effective approaches to deliver drugs across the blood-brain barrier for the treatment of brain diseases.
Harvard University licenses its nasal swab collection technology, developed at the Wyss Institute and Harvard Medical School, to Mass. startup Rhinostics
The combined technologies could reduce labor and time required for COVID-19 diagnostic testing 10-fold, and facilitate future diagnostic testing of other respiratory diseases.
NORTHPOND VENTURES: Harvard's Wyss Institute Creates Research And Innovation Alliance With Northpond Labs
Northpond commits $12 million to create a Laboratory for Bioengineering Research and Innovation at the Wyss Institute for solutions-oriented research and development
New low-cost nasopharyngeal swabs can be manufactured quickly to address the international shortage of swabs for testing and research
Wyss Institute researchers are confronting the coronavirus crisis on all fronts -‑ by rapidly developing much needed diagnostic and therapeutic inventions
Combination gene therapy developed at Wyss Institute and Harvard Medical School treats four age-related conditions
Hansjörg Wyss, Harvard M.B.A. '65, Gives Unprecedented Third Major Gift to Harvard to Support the Wyss Institute's Mission to Develop and Commercialize World-Changing Technologies
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced the latest gift of $131 million from its founding entrepreneur and philanthropist, Hansjörg Wyss.
The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cellectis announced that they will collaborate to further advance the Wyss Institute's efforts to recode the entire genome of cell lines derived from humans and other species, and to develop new tools and methods facilitating this goal.
The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced that Novartis will have access to commercially develop their therapeutic, biomaterial-based, cancer vaccine technology that promotes anti-cancer immunity.